|
|
|
| Comparison of curative effect of short-acting oral contraceptives and estrogen-progesterone sequential therapy for treating women after abortion |
| 1.Jingnan Medical Branch, PLA General Hospital, Beijing, 100071；2.731 Hospital of China Aerospace Science and Industry Corporation |
|
|
|
Abstract To compare the curative effect of short-acting oral contraceptives and estrogen-progesterone sequential therapy for treating women after abortion. Methods: 120 women who underwent abortion were included and were divided into three groups (40 cases in each group) according to the different postoperative treatments between January 2020 and September 2020. The women in the control group were given conventional treatment, and the women in group A were given shortacting oral contraceptives combined with conventional treatment, and the women in group B were given oral estrogen-progesterone sequential therapy combined with conventional treatment. The postoperative recovery status, the sex hormones levels, and the incidence of postoperative complications of the women were compared among the three groups. Results: After treatment, the duration of vaginal bleeding, the menstrual recovery time, and the bleeding volume of the women in group A and in group B were significantly less than those of the women in the control group, and the duration of vaginal bleeding and the bleeding volume of the women in group A were significantly less than those of the women in group B (all P<0.05). The endometrial thickness of the women in group A was significantly thinner than that of the women in group B, and which of the women in both group B and group A after treatment was significantly thicker than that before treatment, and which of the women in both group B and group A was significantly thicker than that of the women in the control group. The score of menstrual discomfort scale (MDQ) of the women in both group B and group A was significantly was significantly lower than that of the women in
the control group (all P<0.05). The levels of follicle-stimulating hormone (FSH), luteinizing hormone, and estradiol of the women had no significant difference between group A and group B, but which of the women in both group B and group A was significantly higher than that of the women in the control group (P<0.05). The incidence of complications (7.5% vs. 5.0%) of the women had no significant difference between group A and group B, but which of the women in both group B and group A was significantly lower than that (32.5%) of the women in the control group (P<0.05). Conclusion: Both Short-acting oral contraceptives and estrogen-progesterone sequential therapy for treating the women after abortion can reduce their postoperative bleeding volume, enhance their menstrual cycle recovery, improve their menstrual discomfort, and increase their sex hormones levels, and reduce their postoperative complications.
|
|
|
|
|
|
|
|
|
